Oisin Biotechnologies Email Format
Biotechnology ResearchWashington, United States11-50 Employees
Oisin Biotechnologies operates in the biotechnology research sector with a focus on longevity therapies. The company develops genetic medicines designed to target and clear senescent cells, which accumulate with age when damaged cells fail to undergo normal cell death. Senescent cells release inflammatory signals that contribute to inflammation and various age-related diseases, and their removal is proposed to mitigate aging-related pathology and improve survival outcomes.